Cargando…
Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trial
The ASPREE randomized controlled trial (2010–2017) of 19,114 community-dwelling older adults without cardiovascular disease and significant disability compared daily 100mg aspirin to placebo. A total of 16,317 (93%) of 17,546 surviving and non-withdrawn participants agreed to continue regular study...
Autores principales: | Wolfe, Rory, Broder, Jonathan, Chan, Andrew, Murray, Anne, Orchard, Suzanne, Polekhina, Galina, Ryan, Joanne, Tonkin, Andrew, Webb, Katherine, Woods, Robyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516076/ https://www.ncbi.nlm.nih.gov/pubmed/37745426 http://dx.doi.org/10.1101/2023.09.13.23295514 |
Ejemplares similares
-
ASPREE SUB-STUDIES
por: Woods, Robyn L, et al.
Publicado: (2019) -
Overcoming challenges to data quality in the ASPREE clinical trial
por: Lockery, Jessica E., et al.
Publicado: (2019) -
Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
por: Robman, Liubov D., et al.
Publicado: (2020) -
A multistate model of health transitions in older people: a secondary
analysis of ASPREE clinical trial data
por: Neumann, Johannes T, et al.
Publicado: (2022) -
POTENTIAL IMPLICATIONS OF ASPREE ON ASPIRIN PRIMARY PREVENTION GUIDELINES
por: Murray, Anne M
Publicado: (2019)